AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-K$CURLF

Curaleaf Reports Third Quarter 2026 Results: Record Revenue and Robust Profitability

Curaleaf Holdings, Inc. (CURLF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Curaleaf Reports Third Quarter 2026 Results: Record Revenue and Robust Profitability Third quarter 2026 net revenue of $353 million Third quarter 2026 International revenue of $59 million Third quarter 2026 adjusted gross profit margin of 49% Third quarter adjusted EBITDA of $78

Original reporting
SEC EDGAR 8-K
Published Nov 3, 2026, 9:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 9:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CURLF
Bullish
high confidence
Mentioned
$CURLF
Relevance
8/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CURLFBullishHigh
01

Why it matters

The earnings beat and record revenue provide a fresh catalyst for the stock, likely prompting short‑term buying pressure.

02

Market read

First‑report earnings for a mid‑cap cannabis company; potential sector‑wide ripple effect.

03

What to watch

High debt level ($637M) and modest cash balance may limit upside.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Curaleaf Holdings, Inc. (OTCQX:CURLF, TSX:CURA) filed a Form 8‑K reporting its third‑quarter 2026 financial results.

Company-level read

Ticker impact

$CURLFBullishHigh confidence
Context

Curaleaf reported Q3 2026 record revenue of $353M and adjusted EBITDA of $78M, beating prior expectations.

Expected impact

upward pressure as investors price in stronger revenue and profitability.

Evidence & confidence

Record revenue and solid margin expansion suggest better-than-expected performance, which typically drives short-term buying.

Market effects

Sector

Cannabis sector may see broader rally on strong earnings from a leading player.

Regional

U.S. cannabis stocks could benefit from Curaleaf's performance.

Global

Limited to cannabis industry; no broader macro impact.

Counterpoint

What could challenge this read

If guidance falls short of growth expectations, the stock could face profit-taking.

Key entities

  • company
    Curaleaf Holdings, Inc.

    Leading international cannabis producer.

  • executive
    Boris Jordan

    Chairman and CEO of Curaleaf.

Read at source← All news

StoryCuraleaf posts record Q3 2026 revenue and narrows loss while pursuing Aurora Cannabis acquisition

Also covered by

5 outlets

Related articles

$CURLFMedAI 8/10

Curaleaf Holdings Inc (CURLF) (Q3 2026) Earnings Call Highlights: Record $353 Million

Curaleaf reported Q3 2026 revenue of $353M, up 11% YoY, with adjusted gross margin down 190bps to 49%. German market price compression and operational disruptions impacted margins. Net loss was $37M. Q4 revenue guidance suggests 1-2% sequential growth. CEO Boris Jordan discussed potential bid improvements for Aurora and regulatory challenges. Capital expenditures are expected to be $80M, limiting free cash flow.

finance.yahoo.com
Med

Curaleaf Q3 Revenue Hits Record $352.7 Million as Margins Contract

Curaleaf Holdings reported Q3 2026 revenue of $352.7M, up 10.9% YoY, but margins contracted. Net loss was $37.4M. Domestic revenue rose 8% to $294M, while international revenue grew 28% to $58.7M. Adjusted EBITDA increased to $77.6M. The company aims for $150M in full-year operating cash flow, with $104.9M cash and $636.9M debt at Q3 end. It also pursued Aurora Cannabis acquisition.

securities.io